Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Consolidated Appropriations Act, 2024: The Impact on Workers' Compensation and Auto Casualty Sectors
On March 9, 2024, President Biden signed the Consolidated Appropriations Act of 2024 into law. The spending package reduced the Medicare Physician Fee Schedule (MPFS). As a result, any state that uses Medicare as its fee schedule could see significant impacts from recent Medicare adjustments.
Quick Guide to Field Case Management Specialty Services
This guide outlines our specialty field case management services, providing clear guidance on when and how to utilize them effectively.
From Airplane Mechanic to Drone Pilot
Discover how we helped a military veteran transition to a new career after a shoulder injury, saving his employer over $28,000 and achieving a successful vocational outcome.
Cost Projections Services and Legal/Liability Nurse Reviews
This presentation will delve into the definition, utilization, and value of these services, case studies and best practices.
Best Practices in Workers' Compensation Utilization Review
This course aims to help claims professionals and clinical staff navigate these jurisdictional complexities by focusing on developing a better unde
Comp industry wary of rise of migraine meds
In the article, Nikki Wilson says a big reason these meds are rising in comp is due to their effectiveness for treating injured employees who sustain traumatic brain injuries or other triggers on the claim related to migraines.